Welcome to PsychU!

Impact Of Covid-19 Pandemic On Women’s Mental Health

Women have been impacted by the Covid-19 pandemic in relation to their overall mental health, with increased reported rates of depression and anxiety.1

Dr. Weinstock will be discussing the impact of Covid-19 pandemic on women’s mental health, along with the risk of trauma in women during the pandemic. Finally, she will discuss the effects of the pandemic in women in the medical profession. 

1 Lindau ST, et al 2021. https://doi.org/10.1089/jwh.2020.8879

Featuring: 

Lisa Weinstock, MD

  • Clinical Assistant Professor, New York Medical College

Jehan Marino, PharmD, BCPP

  • Senior Clinical & Scientific Liaison
  • Otsuka Pharmaceutical Development & Commercialization, Inc.

Lisa Weinstock, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
Jehan Marino, PharmD, BCPP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. 

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.

US.CORP.X.21.00792 / US.CORP.X.21.00793